|
Match
|
Document |
Document Title |
|
|
US20110098284 |
Methods and compositions for treating pain
The present invention provides a method of treating or preventing pain, inflammation or fever comprising administering to a subject in need of such treatment or prevention a therapeutically... |
|
|
US20110015134 |
Method of treatment for early stage cancer
This patent describes a method and materials to treat cancer diagnosed at an early stage, particularly breast cancer. It considers that metastatic breast cancer growth includes periods of... |
|
|
US20110293721 |
PIROXICAM-CONTAINING MATRIX PATCHES AND METHODS FOR THE TOPICAL TREATMENT OF ACUTE AND CHRONIC PAIN AND INFLAMMATION THEREWITH
This invention relates to matrix patches for the topical (i.e., transdermal) delivery of piroxicam and methods for the treatment of acute and chronic pain and inflammation therewith, particularly... |
|
|
US20110237563 |
FAST DISSOLVING DRUG DELIVERY SYSTEMS
The present invention related to the administration of bioactive agents via oral fast dispersing/dissolving drug delivery systems for treating illnesses of patient with critical buccal condition,... |
|
|
US20140024642 |
OPHTHALMIC FORMULATION AND METHOD FOR AMELIORATING PRESBYOPIA
An ophthalmic formulation having an effective amount of a parasympathomimetic agent comprising pilocarpine, or a pharmaceutically acceptable salt thereof, and one or more α1 adrenergic agonists or... |
|
|
US20070244102 |
Combination of Dermaciclane and Opoids as Analgesics
The invention relates to a combined analgesic pharmaceutical composition which comprises as component: A)... |
|
|
US20140179639 |
MELOXICAM FOR THE TREATMENT OF RESPIRATORY DISEASES IN PIGS
A method of treating or preventing a respiratory disease in a pig is described that includes administering to the pig in need thereof an effective amount of meloxicam or a pharmaceutically... |
|
|
US20110086074 |
COMBINATIONS OF NIACIN AND AN OXICAM
Pharmaceutical formulations comprising a combination of niacin and an oxicam NSAID, for oral administration, and methods of preparing the formulations. |
|
|
US20110218191 |
USE OF MELOXICAM FOR THE LONG TERM-TREATMENT OF KIDNEY DISORDERS IN CATS
The invention is directed to a formulation containing NSAIDs or a pharmacologically acceptable salt thereof of and one or more vehicles for the treatment of kidney diseases in cats. Serum... |
|
|
US20140066440 |
Highly Concentrated Stable Meloxicam Solutions for Needleless Injection
A method for treating pain, inflammation, fever and respiratory complaints in mammals comprising administering by needleless injection to a mammal in need of such treatment an aqueous... |
|
|
US20130165430 |
COMPOSITION AND METHOD FOR COMPOUNDED THERAPY
The present embodiments relate to topically delivered compounded medications. A transdermal cream may provide the effective topical administration of multiple medications simultaneously. The... |
|
|
US20150148305 |
COMPOSITION AND METHOD FOR COMPOUNDED THERAPY
The present embodiments relate to topically delivered compounded medications. A transdermal cream may provide the effective topical administration of multiple medications simultaneously. The... |
|
|
US20130165429 |
COMPOSITION AND METHOD FOR COMPOUNDED THERAPY
The present embodiments relate to topically delivered compounded medications. A transdermal cream may provide the effective topical administration of multiple medications simultaneously; may... |
|
|
US20140378401 |
Ophthalmic Lipophilic and Hydrophilic Drug Delivery Vehicle Formulations
The ophthalmic drug delivery vehicles provide comfort and compliance; drug solubility, residence time and permeability; and reduce side effects. In addition, the delivery vehicle can be slightly... |
|
|
US20140378391 |
Ophthalmic Lipophilic Drug Delivery Vehicle Formulations
The ophthalmic drug delivery vehicles provide comfort and compliance; drug solubility, residence time and permeability; and reduce side effects. In addition, the delivery vehicle can be slightly... |
|
|
US20110034448 |
CARBONIC ANHYDRASE INHIBITOR SUSTAINED RELEASE INTRAOCULAR DRUG DELIVERY SYSTEMS
Biocompatible intraocular drug delivery systems include a carbonic anhydrase inhibitor therapeutic agent and a polymeric component in the form of an implant, a microparticle, a plurality of... |
|
|
US20130035330 |
USE OF MELOXICAM FOR THE LONG-TERM TREATMENT OF MUSCULOSKELETAL DISORDERS IN CATS
The invention is directed to the use of a formulation comprising meloxicam or a pharmacologically acceptable meloxicam salt of an organic or inorganic base thereof for the long-term treatment of... |
|
|
US20130195977 |
Low Concentration Meloxicam Tablets
A solid tablet formed through direct compression of powder, the powder comprising meloxicam as an active ingredient and one or more excipients which are homogenously dispersed within the tablet... |
|
|
US20130123245 |
METHODS FOR ALLEVIATING CHRONIC PAIN AND IMPROVING PERFORMANCE OF CATTLE UNDERGOING DEHORNING OR CASTRATION
Methods of improving performance, increasing weight gain, and decreasing incidence of disease in ruminant and pre-ruminant animals, such as cattle, after undergoing painful processing procedures,... |
|
|
US20110158983 |
COMPOSITIONS AND METHODS FOR MUCOSITIS AND ONCOLOGY THERAPIES
In alternative embodiments, this invention provides compositions and methods for treating cancer or any condition caused by dysfunctional cells, side effects from treatments for cancer or any... |
|
|
US20140080794 |
Methods and Compositions for the Treatment of Estrogen-Dependent Hyperproliferative Uterine Disorders
The present invention relates to the treatment of estrogen-dependent hyperproliferative uterine disorders including endometriosis, uterine fibroids, endometrial hyperplasia, uterine cancer, and... |
|
|
US20110280916 |
STABLE HYDROALCOHOLIC ORAL SPRAY FORMULATIONS AND METHODS
Stable formulations of an active pharmaceutical agent suitable for oral spray administration for absorption by the oral mucosa and related methods of preparation and administration of active... |
|
|
US20120213869 |
Pain Relieving Composition
A pain relieving composition that includes an anesthetic in the range of 0.5%-7.0% by weight (“w/w”), an anti-inflammatory agent in the range of 1.0%-11.0% w/w, a moisturizing agent in the range... |
|
|
US20110212948 |
TREATMENT OF NEONATE FOALS WITH MELOXICAM
A method of administering meloxicam containing compositions to neonate foals of 6 weeks of age or less is provided. The inventors have discovered that foals of 6 weeks of age or less can have... |
|
|
US20120121567 |
OPHTHALMIC SOLUTION FOR PROTECTING INTERNAL STRUCTURES OF THE EYEBALL AGAINST UV-A RAYS OR FOR THE TREATMENT OF KERATOCONUS WITH A TRANS-EPITHELIAL CROSS-LINKING TECHNIQUE
An ophthalmic solution containing riboflavin and at least a compound chosen in the group composed of essential and conditionally essential amino acids, coenzyme Q, L-proline, glycine, lysine... |
|
|
US20150190417 |
CHEWABLE FORMULATION
The present invention relates to a chewable formulation for delivering a nutritional or pharmaceutically active agent to an animal target. The chewable formulation comprises a nutritional... |
|
|
US20110263545 |
HEPATOPROTECTANT ACETAMINOPHEN MUTUAL PRODRUGS
The present invention provides hepatoprotectant acetaminophen mutual prodrugs, which have an acetaminophen moiety covalently linked to a second moiety that may act as a hepatoprotectant against... |
|
|
US20110178044 |
TRANSDERMAL ADMINISTRATION OF HYDROPHILIC DRUGS USING PERMEATION ENHANCER COMPOSITION
Methods, formulations, and drug delivery systems are provided for enhancing the flux of a transdermally administered hydrophilic drug using a basic permeation enhancer composition. The enhancer... |
|
|
US20120093938 |
ORALLY DISINTEGRATING TABLETS COMPRISING DIPHENHYDRAMINE
The compositions of the present invention comprise a therapeutically effective amount of particles consisting of diphenhydramine or pharmaceutically acceptable salts thereof, optionally in... |
|
|
US20150051198 |
Highly Concentrated Stable Meloxicam Solutions for Needleless Injection
An aqueous cyclodextrin-free solution of meloxicam suitable is provided for administration by needleless injection, containing a pharmacologically acceptable meloxicam salt of an organic or... |
|
|
US20140113893 |
Highly Concentrated Stable Meloxicam Solutions for Needleless Injection
An aqueous cyclodextrin-free solution of meloxicam suitable is provided for administration by needleless injection, containing a pharmacologically acceptable meloxicam salt of an organic or... |
|
|
US20130178467 |
HIGHLY CONCENTRATED STABLE MELOXICAM SOLUTIONS
Aqueous cyclodextrin-free solution of meloxicam for administration by oral or parenteral route, containing a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or... |
|
|
US20120141467 |
Ascorbic acid to treat chronic obstructive lung diseases and non-Hodgkin's lymphoma
Provided herein is a method for treating a tracheo-bronchial-alveolar tract disease in a subject in need thereof, the method comprising the step of administering to a subject in need of such... |
|
|
US20120168335 |
Fast Disintegrating Compositions of Meloxicam, Processes for Preparation, and Use to Treat Arthritis and/or Pain
The invention provides pharmaceutical compositions comprising a therapeutically effective amount of meloxicam, or a pharmaceutically acceptable salt thereof, wherein the pharmaceutical... |
|
|
US20140364384 |
MEDICATION ADHERENCE MONITORING SYSTEM
The present invention relates to the detection of markers in exhaled breath, wherein the detection of the presence or absence of the marker(s) in exhaled breath is used to assess various clinical... |
|
|
US20130317013 |
EP4 RECEPTOR AGONIST, COMPOSITIONS AND METHODS THEREOF
This invention relates to potent selective agonists of the EP4 subtype of prostaglandin E2 receptors, their use or a formulation thereof in the treatment of glaucoma and other conditions which are... |
|
|
US20110217289 |
Melt-Coated Dosage Forms
Formulations of sparingly water-soluble active ingredientscomprising carrier particles provided with active ingredient-containing coatings, the sparingly soluble active ingredients being embedded... |
|
|
US20120213855 |
DOSAGE FORMS FOR WEAKLY IONIZABLE COMPOUNDS
This disclosure relates to dosage forms (e.g., solid dosage forms) comprising a drug-containing emulsion, a drug-containing microemulsion, a self-emulsifying oil composition, or a... |
|
|
US20110151024 |
Compositions and Methods for Preventing Migraines
The present invention relates to compositions and methods for preventing migraines. The migraine prophylaxis composition is a single dosage form comprising at least one form of elemental magnesium... |
|
|
US20140141083 |
NANOPARTICULATE MELOXICAM FORMULATIONS
The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm. |
|
|
US20100297252 |
NANOPARTICULATE MELOXICAM FORMULATIONS
The present invention is directed to nanoparticulate compositions comprising meloxicam particles having an effective average particle size of less than about 2000 nm. |
|
|
US20100297181 |
AMPA Receptor Antagonists for Epilepsy, Mental Disorders or Deficits in Sensory Organ
The invention provides methods for treating epilepsy, mental disorders and/or deficits in sensory organ by administering to patients therapeutically effective amounts of AMPA receptor antagonists... |
|
|
US20080138422 |
Analgesic Compositions
The present invention relates to pharmaceutical compositions comprising an analgesic agent and providing controlled release of the agent for improved treatment and prevention of pain and... |
|
|
US20050288280 |
Meloxicam in veterinary medicine
A veterinary pharmaceutical formulation containing meloxicam or a pharmacologically acceptable meloxicam salt of an organic or inorganic base and one or more vehicles having analgesic efficacy for... |
|
|
US20150111881 |
ACYCLOVIR AND MELOXICAM COMBINATION THERAPY FOR FUNCTIONAL SOMATIC SYNDROMES
The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound acyclovir and a therapeutically-effective... |
|
|
US20150011538 |
VALACICLOVIR AND MELOXICAM COMBINATION THERAPY FOR FUNCTIONAL SOMATIC SYNDROMES
The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound valaciclovir and a therapeutically-effective... |
|
|
US20130203744 |
ACICLOVIR AND MELOXICAM COMBINATION THERAPY FOR FUNCTIONAL SOMATIC SYNDROMES
The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound aciclovir and a therapeutically-effective... |
|
|
US20130203743 |
FAMCICLOVIR AND MELOXICAM COMBINATION THERAPY FOR FUNCTIONAL SOMATIC SYNDROMES
The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound famciclovir and a therapeutically-effective... |
|
|
US20130203742 |
VALACICLOVIR AND MELOXICAM COMBINATION THERAPY FOR FUNCTIONAL SOMATIC SYNDROMES
The present invention relates to pharmaceutical compositions comprising a combination of a therapeutically-effective amount of the antiviral compound valaciclovir and a therapeutically-effective... |
|
|
US20130281397 |
TREATMENT OF DISEASES BY EPIGENETIC REGULATION
The present disclosure provides non-naturally occurring polyphenol compounds that inhibit the bromodomain and extra terminal domain (BET) proteins. The disclosed compositions and methods can be... |